Immediate Impact
60 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Works of Wei‐Chih Su being referenced
KEYNOTE-361: Phase 3 trial of pembrolizumab ± chemotherapy versus chemotherapy alone in advanced urothelial cancer
2018
Phase I/II Study of NC-6004, A Novel Micellar Formulation of Cisplatin, In Combination with Gemcitabine in Patients with Pancreatic Cancer in Asia - Results of Phase I
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Wei‐Chih Su | 356 | 261 | 158 | 184 | 78 | 744 | |
| Xu Guo | 328 | 199 | 201 | 304 | 46 | 859 | |
| Masanori Nishioka | 326 | 309 | 236 | 185 | 73 | 951 | |
| Tatsuhei Kondo | 228 | 147 | 127 | 161 | 73 | 711 | |
| Arkadiusz Jeziorski | 216 | 168 | 132 | 214 | 63 | 754 | |
| Yung‐Yu Hsieh | 158 | 209 | 134 | 370 | 52 | 932 | |
| Tomohiro Kurokawa | 339 | 163 | 136 | 265 | 64 | 951 | |
| Hiroharu Shinozaki | 290 | 215 | 149 | 236 | 60 | 748 | |
| Keisho Kataoka | 279 | 499 | 140 | 203 | 54 | 934 | |
| Masaya Oikawa | 491 | 343 | 235 | 202 | 67 | 827 | |
| Hitoshi Iwata | 171 | 137 | 132 | 198 | 73 | 748 |
All Works
Login with ORCID to disown or claim papers
Loading papers...